Colin Pritchard on Germline and Somatic DNA in Men with Castration-Resistant Prostate Cancer

Colin Pritchard, PhD, presented, "Next-generation or targeted sequencing of germline and somatic DNA in men with CRPC" at the 2017 Advanced Prostate Cancer Consensus Conference: (APCCC) in St. Gallen, Switzerland. Charles Ryan, MD, interviewed Dr. Pritchard on reading a mutation panel and what to look at and what to disregard.  Also, the classification scheme which is used by most labs and his thoughts on commercial testing options that are available and what they focus on.

Abstract by Colin Pritchard: Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

Biographies:
Colin C. Pritchard MD, PhD is an Assistant Professor of Laboratory Medicine. He is also the associate director of the clinical molecular genetics laboratory in Laboratory Medicine at the University of Washington Medical Center, where he focuses on oncology molecular diagnostics.

Charles J. Ryan, MD

Access to all Advanced Prostate Cancer Consensus Conference Video Coverage 

Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe